Updated:
Fujita Innovation Capital
Fujita Innovation Capital is a venture capital firm founded in 2019 in Toyoake, Japan. The firm has made 8 investments, including a Series B - II investment in...
Fujita Innovation Capital
Fujita Innovation Capital is a venture capital firm founded in 2019 in Toyoake, Japan. The firm has made 8 investments, including a Series B - II investment in Metagen Therapeutics on February 25, 2026. Fujita Innovation Capital has 2 portfolio exits, with J-Pharma exiting on March 25, 2026.
General information
Firm type
Private Equity
Year founded
2019
Location
Region
Asia
Country
Japan
City
Toyoake-shi
Corporate office
Toyoake-shi, Aichi, Japan
Sector focus
Frequently asked questions
How does Fujita Innovation Capital source its deal flow?
The firm's primary sourcing advantage is geographic: its Toyoake-shi base places it inside the Chukyo industrial zone, home to Toyota, Denso, Aisin, and hundreds of Tier-1 and Tier-2 suppliers. This physical proximity creates an informal pipeline of spin-outs from corporate R&D labs and university engineering departments that rarely reach Tokyo-based venture funds until later rounds.
Which sectors does Fujita Innovation Capital invest in?
The firm targets deep-tech and industrial sectors tied to Japan's manufacturing economy: industrial automation, robotics, mobility and transportation, enterprise software, and AI/ML applications for the factory floor and supply chain. These sectors map directly onto the expertise base and corporate demand within the greater Nagoya region.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: